Get notified when AGL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsagilon health names Tim O'Rourke CEO with equity tied to $50-$150 stock price targets
Filed April 27, 2026 · Period ending April 24, 2026 · ~1 min read
Key Changes
-
high
Tim O'Rourke appointed CEO and President effective May 7, 2026, bringing healthcare leadership experience from Help at Home, Centene, and Humana. He also joins the Board as a Class III director.
Item 5.02 verify on EDGAR → -
high
O'Rourke receives 200,000 performance stock units vesting in thirds when stock hits $50, $100, and $150 over 30 consecutive trading days within three years—signaling board confidence in major upside.
Item 5.02: Employment Agreement verify on EDGAR → -
medium
Base compensation set at $850,000 salary plus 100% target bonus ($850,000) and $500,000 signing bonus, repayable if he leaves voluntarily or is terminated for cause within one year.
Item 5.02: Compensation verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade AGL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify